Ggp Inc:企業の戦略・SWOT・財務分析

◆英語タイトル:Ggp Inc - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3328
◆発行会社(調査会社):MarketLine
◆発行日:2019年11月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Construction
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Ggp Inc – Strategy, SWOT and Corporate Finance Report
Summary

Ggp Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

GGP Inc. (GGP or “the company”), formerly General Growth Properties, Inc., is real estate company. The company is involved in the operation, development and management of retail and other rental properties. It owns and operates retail properties that consist of retail, dining and entertainment within their trade areas and provide services for communities, retailers, employees, consumers and stockholders. GGP also designs and develops club and offers loyalty program to shoppers. It conducts business through its subsidiaries including GGP Operating Partnership, LP, GGP Nimbus, LP, and GGP Limited Partnership. It operates in the US. The company is headquartered in Chicago, Illinois, the US.

Scope

- Detailed information on Ggp Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ggp Inc in the form of a SWOT analysis
- An in-depth view of the business model of Ggp Inc including a breakdown and examination of key business segments
- Intelligence on Ggp Inc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ggp Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Ggp Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Ggp Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Ggp Inc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
GGP Inc: Company Overview
GGP Inc: Overview and Key Facts
GGP Inc: Overview
GGP Inc: Key Facts
GGP Inc: Key Employees
GGP Inc: Key Employee Biographies
GGP Inc: Major Products and Services
GGP Inc: Company History
GGP Inc: Management Statement
GGP Inc: Locations and Subsidiaries
GGP Inc: Key Competitors
GGP Inc: Company Analysis
GGP Inc: Business Description
GGP Inc: SWOT Analysis
GGP Inc: SWOT Overview
GGP Inc: Strengths
GGP Inc: Weaknesses
GGP Inc: Opportunities
GGP Inc: Threats
GGP Inc: Corporate Financial Deals Activity
GGP Inc: Financial Deals Overview
GGP Inc: Targets and Partners
GGP Inc: Top Deals 2015 – 2019YTD*
GGP Inc: Advisors
GGP Inc: Top Legal Advisors
GGP Inc: Top Financial Advisors
GGP Inc: Mergers and Acquisitions
GGP Inc: Corporate Venturing
GGP Inc: Capital Raising
GGP Inc: Partnership
GGP Inc: Divestments
GGP Inc: Private Equity and Ownership
GGP Inc: Recent Developments
GGP Inc: News and Events Summary
GGP Inc: Contracts
GGP Inc: Corporate Governance
GGP Inc: Financial Deals
GGP Inc: Financial Performance
GGP Inc: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: GGP Inc: Key Facts
Table 2: GGP Inc: Key Employees
Table 3: GGP Inc: Company History
Table 4: GGP Inc: Locations and Subsidiaries
Table 5: GGP Inc: Key Competitors
Table 6: GGP Inc: Deal Activity by Deal Type - Volume (TTM*)
Table 7: GGP Inc: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: GGP Inc: M&A Average Deal Size - Value (US$m)
Table 9: GGP Inc: Targets and Partners
Table 10: GGP Inc: Top Deals 2015 - 2019YTD*
Table 11: GGP Inc: Legal Advisor Ranking by Value (US$m)
Table 12: GGP Inc: Financial Advisor Ranking by Value (US$m)
Table 13: GGP Inc: M&A Volume and Value Trend (2015 - YTD*2019)
Table 14: GGP Inc: M&A Activity by Geography (2015 - YTD*2019)
Table 15: GGP Inc: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 16: GGP Inc: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 17: GGP Inc: Capital Raising by Deal Type (2015 - YTD*2019)
Table 18: GGP Inc: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 19: GGP Inc: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 20: GGP Inc: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 21: GGP Inc: Private Equity and Ownership Volume and Value Trend (2015 - YTD*2019)
Table 22: GGP Inc: Private Equity and Ownership Volume by Deal Type (2015 - YTD*2019)
Table 23: GGP Inc: News and Events Summary
Table 24: GGP Inc: Contracts
Table 25: GGP Inc: Corporate Governance
Table 26: GGP Inc: Financial Deals
Table 27: GGP Inc: Financial Performance
Table 28: GGP Inc: Strategy and Operations

★海外企業調査レポート[Ggp Inc:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nephros Inc (NEPH):企業の財務・戦略的SWOT分析
    Summary Nephros Inc (Nephros) is dialysis device manufacturer. The company offers infection control filters, dialysis ultrafilters, and hemodia filtration systems. Its dialysis ultrafilters includes Endotoxin ten Cartridge filter, SSUmini, DSU-D and SSU-D. Nephros dialysis ultrafilters are intended …
  • Nuformix Plc (NFX):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuformix Plc (Nuformix), formerly Levrett plc, is a pharmaceutical company which develops cocrystal forms of approved small molecules. Its product candidates which are in clinical and pre-clinical development include NXP001, NXP002, and NXP003 for the treatment of oncology supportive care an …
  • Sienna Biopharmaceuticals Inc (SNNA)-医療機器分野:企業M&A・提携分析
    Summary Sienna Biopharmaceuticals Inc (Sienna Biopharmaceuticals) is a biopharmaceutical company that develops innovation therapies for inflammatory skin conditions and aesthetic conditions. It offers topical by design or low systemic exposure technology platform for local treatment Photoparticle th …
  • Swire Pacific Ltd:戦略・SWOT・企業財務分析
    Swire Pacific Ltd - Strategy, SWOT and Corporate Finance Report Summary Swire Pacific Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Crossbeta Biosciences BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Crossbeta Biosciences BV (Crossbeta) is a biotech company that offers drug discovery programs for the treatment of misfolded protein diseases. The company develops drugs against Alzheimer’s, Parkinson’s, Huntington’s disease and ALS. It offers screening of oligomer-specific therapeutics and …
  • Sichuan Chuantou Energy Company Ltd (600674):電力:M&Aディール及び事業提携情報
    Summary Sichuan Chuantou Energy Company Ltd (Sichuan Investment Energy), a subsidiary of Sichuan Investment Group Co Ltd is an investment holding company. The company’s business activities include operation of hydropower stations, thermal power plant and power generation plants. It develops, constru …
  • PAL Holdings, Inc.:企業の戦略・SWOT・財務情報
    PAL Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary PAL Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Coca-Cola HBC AG:企業の戦略・SWOT・財務情報
    Coca-Cola HBC AG - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola HBC AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cryosite Ltd (CTE):企業の財務・戦略的SWOT分析
    Summary Cryosite Ltd (Cryosite) is a healthcare solution provider that offers clinical trials outsourced logistics services to research, medical, pharmaceutical, veterinary and biotechnology industries. The company manufactures stem cell products for both therapeutic use and clinical trials. It prov …
  • Airvolution Energy Limited:電力:M&Aディール及び事業提携情報
    Summary Airvolution Energy Limited (Airvolution) a subsidiary of Electricity Supply Board, is a renewable energy company that develops, construct and operate small onshore wind projects. It provides landowners a secure, long term revenue stream and takes all the financial risk during development of …
  • Soil Machine Dynamics Ltd:企業の戦略的SWOT分析
    Soil Machine Dynamics Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Grunenthal GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Grunenthal GmbH (Grunenthal) is a research-oriented pharmaceutical company. It researches, develops, produces and markets products for the treatment of pain and innovative formulations of established active substances. The company provides new chemical entities including opioids for moderate …
  • Flexsteel Industries Inc (FLXS):企業の財務・戦略的SWOT分析
    Flexsteel Industries Inc (FLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Redrow Plc:企業の戦略・SWOT・財務情報
    Redrow Plc - Strategy, SWOT and Corporate Finance Report Summary Redrow Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Energy Development Corp (EDC):企業の財務・戦略的SWOT分析
    Energy Development Corp (EDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • F. Hoffmann-La Roche Ltd (ROG):医療機器:M&Aディール及び事業提携情報
    Summary F. Hoffmann-La Roche Ltd (Roche) is a biotechnology company, which develops drugs and diagnostics that improve the standard of care in major disease areas. It provides pharmaceuticals in cancer, neuroscience, infection, immunology, ophthalmology, cardiovascular and metabolism, hematology, ne …
  • Catholic University of Leuven:製薬・医療:M&Aディール及び事業提携情報
    Summary Catholic University of Leuven (KU Leuven) is a scientific research and educational service provider that provides bachelors degree, post graduate degree and doctorate degree programs. The university provides educational courses in the areas of psychology and educational sciences, arts, law, …
  • Epic Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Epic Sciences Inc (Epic Sciences) focuses to develop novel diagnostics for personalized treatment of cancer. The company develops AR-V7 test to identify and molecularly characterize circulating tumor cells in a blood sample. It also offers biopharma solutions such as resistance to AR signali …
  • Prima BioMed Ltd (PRR)-製薬・医療分野:企業M&A・提携分析
    Summary Prima BioMed Ltd (Prima BioMed) is a biotechnology company that develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. The company’s products are based on LAG-3 immune control mechanism which is active in the regulation of the T cell immune response. It deve …
  • Whiting Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Whiting Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Whiting Petroleum Corp (Whiting Petroleum) is an independent oil and gas company that develops, produces, acquires and explores crude oil, natural gas and natural gas liquids (NGL) in the Rock …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆